These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33553158)

  • 1. Ectonucleotidase Modulation of Lymphocyte Function in Gut and Liver.
    Savio LEB; Robson SC; Longhi MS
    Front Cell Dev Biol; 2020; 8():621760. PubMed ID: 33553158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease.
    Liberal R; Grant CR; Ma Y; Csizmadia E; Jiang ZG; Heneghan MA; Yee EU; Mieli-Vergani G; Vergani D; Robson SC; Longhi MS
    J Autoimmun; 2016 Aug; 72():102-12. PubMed ID: 27210814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut.
    Longhi MS; Feng L; Robson SC
    Biochem Pharmacol; 2021 May; 187():114417. PubMed ID: 33460629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD39
    Magid-Bernstein JR; Rohowsky-Kochan CM
    J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The abnormal function of CD39
    Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
    Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.
    Borsellino G; Kleinewietfeld M; Di Mitri D; Sternjak A; Diamantini A; Giometto R; Höpner S; Centonze D; Bernardi G; Dell'Acqua ML; Rossini PM; Battistini L; Rötzschke O; Falk K
    Blood; 2007 Aug; 110(4):1225-32. PubMed ID: 17449799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
    Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
    Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous antisense RNA curbs CD39 expression in Crohn's disease.
    Harshe RP; Xie A; Vuerich M; Frank LA; Gromova B; Zhang H; Robles RJ; Mukherjee S; Csizmadia E; Kokkotou E; Cheifetz AS; Moss AC; Kota SK; Robson SC; Longhi MS
    Nat Commun; 2020 Nov; 11(1):5894. PubMed ID: 33208731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 prevents adenosine-mediated immunoregulation by inhibiting CD39 expression.
    Fang F; Cao W; Mu Y; Okuyama H; Li L; Qiu J; Weyand CM; Goronzy JJ
    JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35730568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ENTPD1/CD39 is a promising therapeutic target in oncology.
    Bastid J; Cottalorda-Regairaz A; Alberici G; Bonnefoy N; Eliaou JF; Bensussan A
    Oncogene; 2013 Apr; 32(14):1743-51. PubMed ID: 22751118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of CD39 and CD73 in tumor immunity.
    Kaplinsky N; Williams K; Watkins D; Adams M; Stanbery L; Nemunaitis J
    Future Oncol; 2024; 20(19):1367-1380. PubMed ID: 38652041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte Macrophage Colony-Stimulating Factor-Activated CD39
    Weinhage T; Däbritz J; Brockhausen A; Wirth T; Brückner M; Belz M; Foell D; Varga G
    Cell Mol Gastroenterol Hepatol; 2015 Jul; 1(4):433-449.e1. PubMed ID: 28210690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD39+ regulatory T cells attenuate allergic airway inflammation.
    Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
    Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cluster of Differentiation 39 (CD39) and Purinergic Signaling Pathway in Viral Infections.
    Elsaghir A; El-Sabaa EMW; Ahmed AK; Abdelwahab SF; Sayed IM; El-Mokhtar MA
    Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-27 confers a protumorigenic activity of regulatory T cells via CD39.
    Park YJ; Ryu H; Choi G; Kim BS; Hwang ES; Kim HS; Chung Y
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3106-3111. PubMed ID: 30718407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD39
    Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
    Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
    Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
    Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic signaling during intestinal inflammation.
    Longhi MS; Moss A; Jiang ZG; Robson SC
    J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.